Oncolytics Biotech Inc. (ONCY) - Latest Market Data

Price & Market Data

Price: $0.812

Daily Change: +$0.0218 / 2.69%

Daily Range: $0.782 - $0.82

Market Cap: $96,617,112

Daily Volume: 566,339

Performance Metrics

1 Week: -7.15%

1 Month: -28.51%

3 Months: -20.80%

6 Months: -18.32%

1 Year: 92.24%

YTD: -11.23%

About Oncolytics Biotech Inc. (ONCY)

A financial summary of Oncolytics Biotech Inc. (ONCY). Price: 0.812, daily change: +$0.0218 / 2.69%. Market cap: 96,617,112. Performance from 3-month to 1-year.

Company Details

Employees: 29

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Selected stocks

Texxon Holding Limited (NPT)

Protalix BioTherapeutics, Inc. (DE) (PLX)

OFS Credit Company, Inc. (OCCI)

Cre8 Enterprise Limited (CRE)